SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005201-20-000005
Filing Date
2020-02-06
Accepted
2020-02-06 17:48:43
Documents
2
Period of Report
2020-02-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158102930633002.html 4  
1 FORM 4 wf-form4_158102930633002.xml 4 4396
2 BUKOFZERPOA2019 bukofzerpoa2019.htm EX-24 3248
  Complete submission text file 0001005201-20-000005.txt   9150
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Issuer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O OCERA THERAPEUTICS 525 UNIVERSITY AVENUE, SUITE 610 PALO ALTO CA 94301
Business Address
Bukofzer Stan (Reporting) CIK: 0001663041 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13111 | Film No.: 20583889